Company
Melbourne, VIC
Every investor coverage indicates participated in a round Lumos Diagnostics raised.
Investors whose own portfolio pages list Lumos Diagnostics, even though we haven't found any coverage of the round yet.
| Investor | Listed on |
|---|---|
| Tenmile | its portfolio page ↗ |
Companies Lumos Diagnostics acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Doug Ward | CEO | @AuManufacturing |
Stories naming Lumos Diagnostics. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
News roundup covering Atomo Diagnostics' committed share placement, Tivan's port agreement, KBR's reconciliation plan, Elexon's innovation award, ReNu Energy's hydrogen refuelling brand and EQ Resources' new ore sorter.
Roundup covering Hanwha defence testing, a PPK Group CEO promotion, Immuron's sales growth, an Australian Vanadium retirement, Lumos Diagnostics' $4.75 million placement, and TAFE Queensland scholarships.
Australian rapid antigen test makers AnteoTech, Lumos Diagnostics and Ellume are exporting output while awaiting TGA approval, despite earlier Queensland and federal government funding, as politicians criticise the domestic shortage.